Blog

Executive Order to Change Prescription Drug Prices

Martin Makary/carey.jhu.edu

May 12, 2025, 13:36

Executive Order to Change Prescription Drug Prices

U.S. FDA shared a post on X:

“FDA Commissioner Dr. Martin Makary with Secretary Robert F. Kennedy, Jr., Jay Bhattacharya and Mehmet Oz as President Donald J. Trump signs Executive Order to bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations.”

Martin Makary, 27th Commissioner of the FDA, shared this post, adding:

“The fundamental problem in healthcare is that we’ve had non-competitive markets. We can do little things around the edges, or we can transform those markets to competitive markets, and that’s what this executive order does today.”

Proceed to the video attached to the post.

More posts featuring U.S. FDA.

cancer Donald J. Trump Jay Bhattacharya Jr. Martin Makary Mehmet Oz OncoDaily Oncology prescription drug prices Robert F. Kennedy U.S. FDA U.S. healthcare

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer